UBS Raises Qualcomm Price Target to $235

Analyst: Timothy Arcuri 1 min read Reproduced verbatim
Rating
Neutral
Target
$235
from $170 (+38%)
Upside
+44%
QCOM at $163 today
UBS and Qualcomm logos

What the analyst said

UBS analyst Timothy Arcuri raised the price target on Qualcomm (NASDAQ: QCOM) to $235.00 (from $170.00) while maintaining a Neutral rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

QCOM trades at $163. The 9 analysts who set a target in the last 3 months range from $155 to $400, with a median of $185. This $235 target is 27% above the median.

Since the note QCOM has moved −17% (from $197). 12-month window: day 131 of 365, closes on June 25, 2027.

Track record

This callOpen: QCOM has not reached $235 yet. This 12-month target is scored on June 25, 2027.

Firm track recordUBS: 81% of its 52 targets at least a year old were reached within 12 months (#10 of 26 firms). Accuracy ranking →

UBS on Qualcomm

UBS price targets on Qualcomm

4 calls from April 21, 2026 to July 30, 2026. The target went from $150 to $170 (+13%). The rating stayed Hold.

UBS targetQCOM share price
  1. July 30, 2026Target cut from $235 (−28%)Hold$170
  2. June 25, 2026 This noteTarget raised from $170 (+38%)Hold$235
  3. April 30, 2026Target raised from $150 (+13%)Hold$170
  4. April 21, 2026Earliest call shownHold$150
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.